Company Filing History:
Years Active: 2022
Title: Innovations by MingHsin Li in Pharmaceutical Composition
Introduction
MingHsin Li is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for drug delivery systems. His work focuses on enhancing the stability and bioavailability of medications, which is crucial for effective treatment.
Latest Patents
MingHsin Li holds a patent for a pharmaceutical composition designed for the sustained release delivery of buprenorphine. This innovative composition is an injectable, low viscosity liquid that can form a depot in situ. It is capable of delivering therapeutic levels of buprenorphine over a period ranging from one week to three months. This advancement is particularly important for patients requiring long-term pain management.
Career Highlights
MingHsin Li is associated with Foresee Pharmaceuticals Co., Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in his field.
Collaborations
MingHsin Li collaborates with talented professionals such as Yuhua Li and Chen-Chang Lee. Their combined efforts contribute to the advancement of pharmaceutical technologies and improve patient outcomes.
Conclusion
MingHsin Li's contributions to pharmaceutical compositions demonstrate his commitment to innovation in drug delivery systems. His work not only enhances the effectiveness of medications but also improves the quality of life for patients.